Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

OncoTargets and Therapy Volume 4, 2011 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Review

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer

Eva Muñoz-CouseloBreast Cancer Unit, Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

José Pérez-GarcíaBreast Cancer Unit, Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Javier CortésBreast Cancer Unit, Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, SpainCorrespondence[email protected]

Pages 185-192 | Published online: 14 Nov 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (2)

Keinosuke OKAZAKI, Akiko SASAKI, Yuko TSUNODA, Kanji FURUYA, Mayumi TSUJI, Yuko UDAKA, Hideto OYAMADA, Masahiro HOSONUMA, Haruna SHIRAKO, Taro YASUMOTO, Yuji KIUCHI & Tadanori SASAKI. (2018) Eribulin Treatment Induces High Expression of miR-195 and Inactivates the Wnt/<i>β</i> - catenin Signaling Pathway in Triple-negative Breast Cancer. The Showa University Journal of Medical Sciences 30:3, pages 359-370.
Crossref

Alberto J. Montero, Mauricio Escobar, Gilberto Lopes, Stefan Glück & Charles Vogel. (2011) Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?. Current Oncology Reports 14:1, pages 1-11.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references